Novartis AG
CYCLODEXTRIN-BASED POLYMERS FOR THERAPEUTIC DELIVERY
Last updated:
Abstract:
Methods and compositions relating to CDP-proteasome inhibitor conjugates are described herein.
Status:
Application
Type:
Utility
Filling date:
25 Jun 2020
Issue date:
15 Oct 2020